Immediate Impact

1 by Nobel laureates 1 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Skin-Interfaced Wearable Sweat Sensors for Precision Medicine
2023 Standout
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
2 intermediate papers

Works of P. Vic being referenced

Non‐classic cystic fibrosis associated with D1152H CFTR mutation
2009
Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis
1998

Author Peers

Author Last Decade Papers Cites
P. Vic 196 40 80 85 30 344
George Karachalios 65 77 53 125 29 389
J. D. Price 54 54 52 74 31 380
Ayşe Berna Anıl 166 60 28 129 50 389
Muhammet Şükrü Paksu 53 70 45 88 32 320
Abd Elazeez Shabaan 152 55 61 155 13 381
C Stathakis 33 39 90 106 25 317
A Sánchez 54 86 46 94 28 407
Alan B Osher 318 62 22 35 15 398
Christine A. Lindsay 96 85 74 138 24 406
Christine M. Wollschlager 147 61 101 138 18 399

All Works

Loading papers...

Rankless by CCL
2026